Searched for
BREAST CANCER
‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...02 Oct, 2026, 01.05 AM IST- Shah Rukh Khan’s co-star survived a horrific car crash, had 67 glass pieces removed from her face, then battled cancer. How did she rebuild her life?Mahima Chaudhry’s journey has been marked by resilience. After a horrific 1999 car crash left 67 pieces of glass embedded in her face, she ...01 Oct, 2026, 10.22 AM IST
- Lord’s Mark secures MHRA registration for dialysis device, plans UK expansionLord's Mark Industries Limited has successfully secured regulatory registration from the MHRA for its innovative haemodialysis machine, pav...30 Sep, 2026, 05.54 PM IST
- In Iowa, soaring cancer rates emerge as a key midterms issueCancer has emerged as an unusual bipartisan campaign issue in Iowa’s midterm races as the state confronts the second-highest cancer rate in...29 Sep, 2026, 03.55 PM IST
- Kerala HC says exorbitant drug prices can trigger government intervention in patented medicinesThe Kerala High Court ruled that government intervention is permissible for prohibitively priced patented medicines. The court directed the...29 Sep, 2026, 12.48 AM IST
- Sun Pharma signs major deal with LIB Therapeutics of US, gains access to $3.7-bn global market for bad cholesterol inhibitor PCSK9Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers al...28 Sep, 2026, 11.48 AM IST
- India needs five-year policy to make precision cancer care afforable, says expertIndia needs a five-year roadmap to expand access to genomic testing and targeted cancer therapies for lower-income patients, oncologist Dr ...26 Sep, 2026, 02.18 PM IST
- Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...26 Sep, 2026, 01.56 PM IST
- Lord’s Mark advances AI breast cancer screening towards clinical trialsIn a groundbreaking collaboration with C-MET, Lord's Mark Industries Limited is making strides in breast cancer screening technology. Utili...25 Sep, 2026, 05.17 PM IST
- Zydus gearing up for next phase of growth, eyeing new areas: Sharvil Patel, MD"From 2030 and beyond, we will see strong earnings from pure discovery-led business, which is our central business, our oncology business a...23 Sep, 2026, 10.37 PM IST
- Sacred Games actress helped build 200 toilets, a school and a canal in Maharashtra village. Who is Rajshri Deshpande? Her education qualifications and careerShe created a niche for herself in Bollywood through critically acclaimed TV series and films such as The Sacred Games, Angry Indian Goddes...22 Sep, 2026, 01.27 PM IST
- Global Market: European shares rise as oil slide boosts risk appetiteEuropean shares rose as technology stocks led gains and falling oil prices eased inflation concerns. The STOXX 600 advanced 0.56%, while in...21 Sep, 2026, 02.17 PM IST
- Biocon arm gets positive EMA panel recommendation for breast cancerbiosimilar PebrilzoBiocon Biologics has received a positive recommendation from the European Medicines Agency’s CHMP for its Pertuzumab biosimilar, Pebrilzo, ...21 Sep, 2026, 01.13 PM IST
- Meet Mercer Henderson, the 13-year-old tech entrepreneur who created digital products and turned app purchases into donations for nonprofit organizationsMercer Henderson, a young entrepreneur, developed innovative apps like Audiots and FriendIts. Audiots allowed users to add sounds to emojis...17 Sep, 2026, 05.55 PM IST
- AstraZeneca's breast cancer drug fails in late-stage trialAstraZeneca's breast cancer drug Etcamah did not meet its main goal in a late-stage trial. The drug showed only a numerical improvement whe...12 Sep, 2026, 04.24 PM IST
- Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in BrazilBiocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis re...08 Sep, 2026, 11.18 AM IST
- Biocon signs 10-year Brazil supply deal for Pertuzumab breast cancer drugIn a significant move, Biocon has secured a ten-year contract in Brazil for the distribution of Pertuzumab, made possible through its colla...08 Sep, 2026, 08.41 AM IST
Load More
